News

Candel Therapeutics Announces Participation in Key Investor Events

Candel Therapeutics Announces Participation in Key Investor Events

Engagement in Investor Conferences

Candel Therapeutics, Inc. (NASDAQ: CADL) has recently announced its participation in important investor conferences where its President and CEO, Paul Peter Tak, will be engaging with potential and current investors. This provides a significant opportunity for stakeholders to gain insights into the company’s innovative approach to cancer treatment.

Details of Upcoming Conferences

The following are the specifics of the investor conferences where Candel Therapeutics will be present:

Citi's Biopharma Conference

This conference will take place on September 3, 2025, at 9:00 AM ET. It is an excellent platform for Candel’s leadership to discuss the progress of their clinical programs. Investors can look forward to a dynamic presentation and a fireside chat, offering a closer look at the company’s strategy and goals.

Cantor Global Healthcare Conference

On September 4, 2025, starting at 8:00 AM ET, Candel Therapeutics will also participate in the Cantor Global Healthcare Conference. This event is an essential venue for discussing the latest advancements in cancer therapies and the company’s unique solutions.

H.C. Wainwright Global Investment Conference

The following day, on September 5, 2025, Candel will be presenting at the H.C. Wainwright 27th Annual Global Investment Conference at 7:00 AM ET. The presentations across these conferences are tailored to provide valuable perspectives on Candel's development pipeline and future prospects in the biopharmaceutical sector.

Access to Live Webcasts

For those who cannot attend the conferences, Candel Therapeutics will provide live webcasts of their presentations. Investors can readily access these webcasts by visiting the Investors section on the company's website under the Events and Presentations tab. This commitment to transparency and communication is crucial for building trust and fostering stakeholder engagement.

About Candel Therapeutics

Candel Therapeutics is leading the charge in cancer treatment through innovative multimodal biological immunotherapies. These therapies are designed to harness and enhance the body's immune response, targeting tumors more effectively. The company's lead product candidate, CAN-2409, demonstrates promising potential in clinical-stage trials, particularly for cancers that are traditionally difficult to treat such as non-small cell lung cancer and localized prostate cancer.

Recent Clinical Trials

Candel has recently completed a phase 2a clinical trial for CAN-2409, yielding encouraging results for patients suffering from non-small cell lung cancer and pancreatic ductal adenocarcinoma. Furthermore, the Food and Drug Administration (FDA) has recognized CAN-2409 with several designations aimed at speeding the development of this essential treatment within specific patient populations.

Innovative Platforms for Cancer Therapy

Alongside CAN-2409, Candel is advancing another candidate, CAN-3110, which is under investigation in a phase 1b clinical trial targeted at treating recurrent high-grade glioma. These contributions are complemented by Candel's enLIGHTEN™ Discovery Platform, demonstrating a commitment to harnessing advanced research methodologies and human biology to discover innovative therapies.

Contact Information

For any inquiries regarding Candel’s investor relations, contact:

Theodore Jenkins
Vice President, Investor Relations and Business Development
Candel Therapeutics, Inc.
Email: tjenkins@candeltx.com

Frequently Asked Questions

What is the focus of Candel Therapeutics?

Candel Therapeutics focuses on developing multimodal biological immunotherapies to enhance cancer treatment.

What are the key upcoming conferences for Candel?

Candel will participate in Citi's Biopharma Conference, Cantor Global Healthcare Conference, and H.C. Wainwright Global Investment Conference.

How does Candel communicate with its investors?

Candel provides live webcasts of its presentations during conferences and maintains an updated Investors section on its website.

What is CAN-2409?

CAN-2409 is Candel's lead product candidate, currently investigated in clinical trials for its effectiveness in fighting cancer.

Who should investors contact at Candel Therapeutics?

Investors can contact Theodore Jenkins, the Vice President of Investor Relations, for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 5

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 5

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 4

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 6

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 8

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 5

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Updated Category News Views 7

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Continue Reading

Top 5 Most Recently Viewed Articles

Gold Prices React to Tariff Announcements and Global Tensions

Updated Category News Views 299

Gold Prices Decline Amid Tariff Announcement The price of gold has faced a notable decline, representing the largest drop in three months. This shift comes as the U.S. government aims to clarify its tariff plans concerning bullion imports. Understanding the Tariff Impact On the latest trading day, the front-month gold futures contract on the NYMEX exchange fell by 2.1%,...

Continue Reading
Candel Therapeutics Announces Participation in Key Investor Events

Updated Category News Views 96

Engagement in Investor Conferences Candel Therapeutics, Inc. (NASDAQ: CADL) has recently announced its participation in important investor conferences where its President and CEO, Paul Peter Tak, will be engaging with potential and current investors. This provides a significant opportunity for stakeholders to gain insights into the company’s innovative approach to...

Continue Reading
Federated Hermes Details Earnings Call for Q3 2025 Results

Updated Category News Views 138

Federated Hermes Earnings Announcement for Q3 2025 Federated Hermes, Inc. (NYSE: FHI), a leader in global active investment management, is preparing to share its financial results for the quarter ending September 30, 2025. The announcement will take place following market closure on Thursday, October 30, 2025. This timely report is crucial for stakeholders and potential...

Continue Reading
Barry Adcock Joins Quantalytix to Enhance Sales Strategy

Updated Category News Views 214

Quantalytix grabbed headlines when they brought in Barry Adcock as their new Sales Executive to tighten the screws on banking performance and risk management. You remember those days when banks were floundering—Adcock's the guy who's been through it all, from being CFO to navigating through the mud of economic downturns. Adcock's Banking Mastery: Navigating Challenges...

Continue Reading
Key Highlights of Man Group PLC's Public Disclosure on Spirent

Updated Category News Views 118

Understanding Man Group PLC's Disclosure Man Group PLC is a prominent player in the financial services sector, known for its investment management solutions. As part of regulatory compliance, the company has recently announced its public opening position disclosure regarding its interests in Spirent Communications plc. This disclosure not only reflects Man Group's...

Continue Reading